Study Investigates Diverse Molecular Mechanisms Driving Treatment Resistance in AML

Researchers evaluated  the primary mechanisms governing drug resistance and relapse in patients treated with crenolanib, an FLT3 inhibitor.

Source: CancerNetwork - February 6, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news